RBRC09802 C (3-6 months) SPTLCはスフィンゴ脂質生合成、初発酵素であり細胞の生存に必須である。全身ノックアウトしたホモマウスは胎生初期に死ぬ。本マウスは組織特異的なノックアウトが可能であり、スフィンゴ脂質の研究に有用である。 B6;129(FVB)-Sptlc2<tm1.1Yhir> B6;129(FVB)-Sptlc2<tm1.1Yhir> 理研と阪大との共同研究で樹立した。Cre-を選抜し、fl/flの作出を行い、胚保存を実施した。 Necessary documents for ordering:<ol><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol> SPTLC2のコンディショナルKO Developed by Yoshio Hirabayashi, RIKEN Brain Science Institute in collaboration with Osaka University. R1 ES cell line [(129X1/SvJ x 129S1/Sv)F1] was used. Exon 3 was replaced with a fragment loxP-neo-loxP-Exon3-loxP. Neo fragment was removed by crossing with an EIIa-Cre mouse strain. Sptlc2(serine palmitoyltransferase, long chain base subunit 2)floxed mice. Homozygous null mutants are embryonically lethal. R1 [(129X1/SvJ x 129S1/Sv)F1-Kitl<+>] 条件を付加する。<br>研究成果の公表にあたって寄託者の指定する文献を引用する。Exp. Anim., 58, 515-524 (2009).<br>学術機関の学術研究に限る。営利機関の利用希望者は、事前に利用条件等につき寄託者と合意し、提供承諾を得ること。 C(3〜6か月) true Phage P1 loxP sites, mouse Sptlc2 genomic DNA <a href='https://brc.riken.jp/mus/pcr09802'>Genotyping protocol -PCR-</a> In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Exp. Anim., 58, 515-524 (2009).The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. <A HREF="https://mus.brc.riken.jp/ja/mouse_of_month/jun_2017_mm" target="_blank">Mouse of the Month Jun 2017</A>